Skip to main content

The Global Digital Pathology Market Continues To Grow Owing To the Recent Developments Done By Central Market Players in the World

 


Market Overview:

Digital pathology also offers more options for viewing, marking, and sharing images. It makes it easier for pathologists to search for cases with similar features, share slides with colleagues, and build predictive models. Using cloud storage means pathologists from around the world can access images and collaborate with one another. Using digital slides can also improve patient care. The benefits of digital pathology go beyond the ability to distribute digital slides. Digital images can be used for specialized analytics, some of which incorporate artificial intelligence. There are some downsides to digital pathology, however. It is important to weigh the benefits of digital pathology with its drawbacks. It may cause some delays in the workflow, but the benefits outweigh the disadvantages.

Competitive Landscape:

Major players operating in the global digital pathology market include Paige, Motic, Mikroscan Technologies, Kanteron Systems, Proscia Inc., PathAI, Inspirata, Inc., KONFOONG BIOTECH INTERNATIONAL CO., LTD., Glencoe Software, OptraSCAN, Sectra AB, Objective Pathology Services, Indica Labs, Corista, Akoya Biosciences, Aiforia Technologies Oy, Visiopharm A/S, Huron Digital Pathology, XIFIN, Inc., Apollo Enterprise Imaging, 3DHISTECH, F. Hoffmann-La Roche Ltd., Hamamatsu Photonics, Koninklijke Philips N.V., and Leica Biosystems.

Key Market Drivers:

Increasing developments related to the global digital pathology market are expected to augment the growth of the market, For instance, in September 2021, Visiopharm and Agilent Technologies, Inc. partnered in order to co-market Visiopharm’s CE-IVD marked Artificial Intelligence-driven Precision Pathology software, along with the automated pathology staining solutions of Agilent. Although digital pathology has only just begun to enter the clinical world, it already offers many benefits. Digital pathology tools can help pathologists make faster, more accurate diagnoses. They can also share results with other experts, and they can be shared in educational settings. The increasing expansion of pathology labs in the world is estimated to enhance the growth of the global digital pathology market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several developments in the global digital pathology market. For instance, in April 2021, Paige.AI, Inc. and Leica Biosystems collaborated on Paige’s AI-enabled research software to aid in grading and tumor detection. 

Key Takeaways:

·         North America is expected to dominate the growth of the global digital pathology market, owing to the recent developments by key players in the region. For instance, in August 2020, Bio-Techne Corporation and Leica Biosystems collaborated in order to automate RNAscope COVID-19 probes on Leica’s BOND RX platform for research purposes.

·         Europe is estimated to witness high growth in the global digital pathology market, owing to the high expansion of key market players in the region. For instance, in August 2021, University Medical Center Utrecht and Sectra AB signed went in a partnership, in order to use Sectra’s pathology module.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...
Post a Comment
Read more

Virology Testing Market Detailed In New Research Report 2023

  Virology testing consist of diagnostic methods that help in early detection of the disease such as hepatitis, influenza, HIV, sexually transmitted disease, RCV, and other viral associated disease. Virology testing examines for detection of viral antigens, nucleic acids, and antibodies in the given sample in order to confirm the presence of particular viral infection. There are more than 100 viral diseases identified. Virology Testing Market- Market Dynamics Virology testing market is projected to witness significant growth during forecast period with rising prevalence of virus originated diseases such as flu, hepatitis, AIDS, and STDs, Ebola, Influenza based viral infections, severe acute respiratory syndrome from coronavirus, hemorrhagic fever etc. across world. Early and fast diagnosis of virus infection is very essential to start treatment course. According to the World Health Organization (WHO), January 2018 factsheet, all types of influenza in combination causes annual...
Post a Comment
Read more

Rabies Vaccines Market Witnesses Upward Trend Due to Increasing Number of Companion Animals

  The rabies vaccine is an important vaccine used to protect against rabies, a deadly disease that kills animals in many countries. There are many different rabies vaccines on the market that both effective and safe. They may be used as a preventative measure to prevent rabies in time of exposure, prior to, and after, contact with the rabies-causing virus, which is most commonly acquired by a dog bite or other animal bite. Rabies is one of the most severe zoonotic diseases that can infect humans through bites of animals such as raccoons, dogs, cats, bats, and foxes. Global Rabies Vaccines Market- Drivers Key players are focused on research and development strategies which are expected to drive the global rabiesvaccine market growth during the forecast period. For instance, in 2017, CPL Laboratories (India), a joint venture biotechnology company established in 2009 by Novavax Inc., USA and Cadila Pharmaceuticals Limited, stated that Nano- particle vaccine of baculvirous-derived...
Post a Comment
Read more